Solarvest BioEnergy Inc.
SVSH.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -41.30% | -60.71% | -44.20% | -72.86% | 28.38% |
| Depreciation & Amortization | -32.14% | -166.67% | -14.50% | -14.39% | -28.21% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -35.43% | -82.04% | -60.32% | -74.55% | -48.47% |
| Operating Income | 35.43% | 82.03% | 60.31% | 74.55% | 48.43% |
| Income Before Tax | 25.83% | 75.96% | 52.96% | 90.86% | 42.00% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 25.83% | 75.96% | 52.96% | 90.86% | 42.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.83% | 75.96% | 52.96% | 90.86% | 42.00% |
| EBIT | 35.43% | 82.03% | 60.31% | 74.55% | 48.43% |
| EBITDA | 35.65% | 83.55% | 61.47% | 76.81% | 49.74% |
| EPS Basic | 25.93% | 76.47% | 54.74% | 91.25% | 47.06% |
| Normalized Basic EPS | 23.53% | 76.47% | 55.74% | 73.91% | 46.88% |
| EPS Diluted | 25.93% | 76.47% | 54.74% | 91.25% | 47.06% |
| Normalized Diluted EPS | 23.53% | 76.47% | 55.74% | 73.91% | 46.88% |
| Average Basic Shares Outstanding | 0.00% | -0.05% | 5.15% | 9.69% | 9.79% |
| Average Diluted Shares Outstanding | 0.00% | -0.05% | 5.15% | 9.69% | 9.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
